ArticleGut and liver2015
Clinicopathologic characteristics of interval gastric cancer in Korea.
Article in Gut and liver, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 29 citations in OpenAlex.
- Diagnostic Performance and Potential Harms of Population-Based Esophagogastroduodenoscopy for Gastric Cancer Screening.Gut and liver · 2026Article
- Post-endoscopy esophageal squamous cell carcinoma with invasion of the muscularis mucosa or deeper detected in surveillance endoscopy after esophageal endoscopic resection.Esophagus : official journal of the Japan Esophageal Society · 2025Article
- Clinical features of gastric adenoma detected within 3 years after negative screening endoscopy in Korea.Gastroenterology report · 2023Article
- Assigning a different endoscopist for each annual follow-up may contribute to improved gastric cancer detection rates.Endoscopy international open · 2022Article
- Association of Regular Endoscopic Screening with Interval Gastric Cancer Incidence in the National Cancer Screening Program.Journal of clinical medicine · 2021Article
- Quality management system for screening esophagogastroduodenoscopy improves detection ofEndoscopy international open · 2021Article
- Gastric Cancers Missed at Upper Endoscopy in Central Norway 2007 to 2016-A Population-Based Study.Cancers · 2021Article
- Characteristics of interval gastric neoplasms detected within two years after negative screening endoscopy among Koreans.BMC cancer · 2021Article
- RNF43 and PWWP2B inhibit cancer cell proliferation and are predictive or prognostic biomarker for FDA-approved drugs in patients with advanced gastric cancer.Journal of Cancer · 2021Article
- Common Locations of Gastric Cancer: Review of Research from the Endoscopic Submucosal Dissection Era.Journal of Korean medical science · 2019Review
- The Characteristics and Prognosis of Diffuse-Type Early Gastric Cancer Diagnosed during Health Check-Ups.Gut and liver · 2017Article
- Periodic Endoscopies Might Not Increase the Detection of Early Gastric Cancer in a Young Population.PloS one · 2016Article
- Feasibility of terahertz reflectometry for discrimination of human early gastric cancers.Biomedical optics express · 2015Article
- Lessons from interval gastric cancer: read between the lines.Gut and liver · 2015Article
Corrections and comments
- Commented on by
Authors and funding
8 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND/
aimsInterval gastric cancer (IGC) is defined as cancer that is diagnosed between the time of screening and postscreening esophagogastroduodenoscopy (EGD). Un-fortunately, little is known about the characteristics of IGC in Korea, a country with a high incidence of gastric cancer. The aim of this study was to evaluate the clinicopathologic char-acteristics of IGCs in Korea.
methodsFrom January 2006 to July 2011, a total of 81,762 subjects underwent screening EGD at Yonsei University Health Promotion Center, Seoul, Ko-rea. We defined missed cancer as cancer diagnosed within 1 year of screening EGD and latent cancer as cancer diag-nosed more than 1 year after EGD.
resultsA total of 16 IGC patients (17 lesions; three missed cancers and 14 latent can-cers) were identified, with a mean age of 60.68 years and a mean interval time of 19.64 months. IGCs tended to be undifferentiated (12/17, 70.6%), located in the lower body of the stomach (12/17, 70.6%) and exhibited flat/depressed endoscopic morphology (11/17, 64.7%). The patients with missed cancer were generally younger than the patients with latent cancer (51.3 years vs 62.8 years, p=0.037), and the patients with undifferentiated cancer were significantly younger than those with differentiated cancer (57.0 years vs 68.8 years, p=0.008).
conclusionsIGCs tended to be undif-ferentiated, located in the lower body of the stomach, and exhibited flat/depressed endoscopic morphology. (Gut Liver, 2015;9167-173).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.